ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, today announced the promotion of Susheel Pillai as the new CEO of ACG Inspection. Pillai has been associated...

Blenrep becomes first anti-BCMA approved globally

GlaxoSmithKline (GSK) has secured US approval for Blenrep (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed or refractory multiple myeloma. This indication...

Joint investment sees UK gov secure pipeline of coronavirus vaccine candidate

The UK government and biotech Valneva have jointly invested in a Scottish facility to bolster vaccine manufacturing capacity. The multi-million-pound investment will allow the government...

View the Online Magazine

- Advertisement -

Launches

Horizon introduces single cell RNAseq-linked CRISPR screening service

Horizon Discovery, a Cambridge, UK-based gene editing specialist, has introduced a single cell RNAseq-linked pooled CRISPR screening to its CRISPR screening services portfolio. The platform...

UK launches antibiotic buying scheme to tackle AMR

The NHS is launching a “pioneering scheme” to provide new antibiotics to patients by offering to pay pharma companies upfront for their work. The move...

First generic remdesivir for COVID-19 treatment launched

Beximco Pharmaceuticals, the Bangladesh-based manufacturer of generic pharma products and APIs, has launched the world’s first generic remdesivir for treating COVID-19. Remdesivir is an antiviral...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

In brief: Sanofi & GSK in talks to supply 300m doses of COVID vaccine to EU

Sanofi and GlaxoSmithKline (GSK) are in “advanced discussions” with the European Commission (EC) for the supply of up to 300 million doses of a...

Arcturus to supply Israel with COVID-19 vaccine candidate

Arcturus Therapeutics has signed an agreement to supply the its COVID-19 vaccine candidate, LUNAR-COV1D, to the Israeli Ministry of Health. Delivery of the vaccine candidate...

Pfizer & BioNTech to supply US with up to 600m doses of COVID vaccine

Pfizer and BioNTech have reached an agreement with the US Department of Health and Human Services and the Department of Defense to meet the...

Pfizer & BioNTech to supply UK with mRNA-based COVID-19vaccine candidate

Pfizer and Germany’s BioNTech has together reached an agreement with the UK to supply 30 million doses of their BNT162 mRNA-based vaccine candidate against...

Approvals

Blenrep becomes first anti-BCMA approved globally

GlaxoSmithKline (GSK) has secured US approval for Blenrep (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed or refractory multiple myeloma. This indication...

FDA rubberstamps Spravato nasal spray for depressive symptoms

US regulators have approved Janssen’s supplemental new drug application (sNDA) for Spravato (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive...

European approval granted for Roche’s Rozlytrek

Roche’s Rozlytrek (entrectinib) has been approved in Europe for the treatment of adult and paediatric patients 12 years of age and older with solid...

Tecentriq combination approved for advanced melanoma

The FDA has approved Roche’s Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients. The safety...

European approval for Novartis’ Cosentyx in paediatric psoriasis

Novartis has gained European approval for Cosentyx (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 to <18 years. The...

Hetero cleared to launch first remdesivir generic in India

Hetero, one of India’s leading generic pharmaceutical companies, has received the manufacturing and marketing approval for remdesivir from the Drug Controller General of India...

Manufacturiung

Finance

Majority of top pharma firms report YoY growth in 2019 – data

In 2019, 17 of the top twenty major pharmaceutical players reported year-on-year revenue growth, according to GlobalData. “One winner was Takeda, which saw more than...

Gilead secures stake in Tizona for $300m

Gilead Sciences will invest $300 million to acquire a 49.9% equity interest in Tizona Therapeutics, a privately held company developing first-in-class cancer immunotherapies. Gilead will...

Adagio launches with $50m financing to develop coronavirus antibody portfolio

Adagio Therapeutics has launched this month with the closing of a $50 million Series A financing to advance its portfolio of coronavirus antibodies as...

Pharma companies launch $1bn AMR Action Fund

More than 20 major biopharmaceutical companies have launched the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients...

Research & Development
Latest

Redx out-licenses porcupine inhibitor to AstraZeneca

UK drug discovery and development company, Redx Pharma, has signed a significant out-licensing agreement for its porcupine inhibitor, RXC006, with AstraZeneca. AstraZeneca will take RXC006...

Teva & Alvotech join forces to commercialise biosimilars in US

Israel’s Teva Pharmaceutical and Icelandic biopharma Alvotech have entered into an exclusive strategic partnership for the commercialisation in the US of five biosimilar product...

Merck and Hanmi to develop NASH therapy

Merck and Hanmi Pharmaceutical have entered into an exclusive licensing agreement for the development, manufacture and commercialisation of efinopegdutide, Hanmi’s investigational once-weekly glucagon-like peptide-1...

Intravacc & Celonic to develop, produce novel COVID-19 vaccine

Intravacc, a Dutch viral and bacterial vaccine specialist, and Swiss CDMO, Celonic Group, have signed a research agreement to further design, develop and produce...

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, has expanded its collaboration and license agreement with Daewoong Pharmaceutical Co. Ltd. and AffyXell...

Appointments

ACG promotes Susheel Pillai as the new CEO for Inspection Business

ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, today announced the promotion of Susheel Pillai as the new...

New Chief Medical Officer for Valneva

Valneva, a specialty vaccine company based in France, has appointed Juan Carlos Jaramillo, as Chief Medical Officer and member of the Management Board. Starting 1st...

In brief: New head of R&D for Cellbox Solutions

Germany’s Cellbox Solutions has appointed Lonza Pharma and Biotech’s former Head of Biosolutions R&D as its new Head of R&D. Dr Herbert A. Mueller-Hartmann will...
- Advertisement -

Tecentriq combination approved for advanced melanoma

The FDA has approved Roche’s Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients. The safety...

European approval for Novartis’ Cosentyx in paediatric psoriasis

Novartis has gained European approval for Cosentyx (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 to <18 years. The...